Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study
Antonia, Scott, Prof, Goldberg, Sarah B, MD, Balmanoukian, Ani, MD, Chaft, Jamie E, MD, Sanborn, Rachel E, MD, Gupta, Ashok, MD, Narwal, Rajesh, PhD, Steele, Keith, PhD, Gu, Yu, PhD, Karakunnel, Joyson J, MD, Rizvi, Naiyer A, Prof
Published in The lancet oncology (01.03.2016)
Published in The lancet oncology (01.03.2016)
Get full text
Journal Article
Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial
Nishio, Makoto, Barlesi, Fabrice, West, Howard, Ball, Simon, Bordoni, Rodolfo, Cobo, Manuel, Longeras, Pascale Dubray, Goldschmidt, Jerome, Novello, Silvia, Orlandi, Francisco, Sanborn, Rachel E., Szalai, Zsuzsanna, Ursol, Grigoriy, Mendus, Diana, Wang, Lijia, Wen, Xiaohui, McCleland, Mark, Hoang, Tien, Phan, See, Socinski, Mark A.
Published in Journal of thoracic oncology (01.04.2021)
Published in Journal of thoracic oncology (01.04.2021)
Get full text
Journal Article
Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study
Park, Keunchil, Haura, Eric B, Leighl, Natasha B, Mitchell, Paul, Shu, Catherine A, Girard, Nicolas, Viteri, Santiago, Han, Ji-Youn, Kim, Sang-We, Lee, Chee Khoon, Sabari, Joshua K, Spira, Alexander I, Yang, Tsung-Ying, Kim, Dong-Wan, Lee, Ki Hyeong, Sanborn, Rachel E, Trigo, José, Goto, Koichi, Lee, Jong-Seok, Yang, James Chih-Hsin, Govindan, Ramaswamy, Bauml, Joshua M, Garrido, Pilar, Krebs, Matthew G, Reckamp, Karen L, Xie, John, Curtin, Joshua C, Haddish-Berhane, Nahor, Roshak, Amy, Millington, Dawn, Lorenzini, Patricia, Thayu, Meena, Knoblauch, Roland E, Cho, Byoung Chul
Published in Journal of clinical oncology (20.10.2021)
Published in Journal of clinical oncology (20.10.2021)
Get full text
Journal Article
Ensartinib (X-396) in ALK-Positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study
Horn, Leora, Infante, Jeffrey R, Reckamp, Karen L, Blumenschein, George R, Leal, Ticiana A, Waqar, Saiama N, Gitlitz, Barbara J, Sanborn, Rachel E, Whisenant, Jennifer G, Du, Liping, Neal, Joel W, Gockerman, Jon P, Dukart, Gary, Harrow, Kimberly, Liang, Chris, Gibbons, James J, Holzhausen, Allison, Lovly, Christine M, Wakelee, Heather A
Published in Clinical cancer research (15.06.2018)
Published in Clinical cancer research (15.06.2018)
Get full text
Journal Article
Non-small cell lung cancer with MET amplification: review of epidemiology, associated disease characteristics, testing procedures, burden, and treatments
Yang, Mo, Mandal, Erin, Liu, Frank X, O'Hara, Jr, Richard M, Lesher, Beth, Sanborn, Rachel E
Published in Frontiers in oncology (11.01.2024)
Published in Frontiers in oncology (11.01.2024)
Get full text
Journal Article
Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors
Sanborn, Rachel E, Pishvaian, Michael J, Callahan, Margaret K, Weise, Amy, Sikic, Branimir I, Rahma, Osama, Cho, Daniel C, Rizvi, Naiyer A, Sznol, Mario, Lutzky, Jose, Bauman, Julie E, Bitting, Rhonda L, Starodub, Alexander, Jimeno, Antonio, Reardon, David A, Kaley, Thomas, Iwamoto, Fabio, Baehring, Joachim M, Subramaniam, Deepa S, Aragon-Ching, Jeanny B, Hawthorne, Thomas R, Rawls, Tracey, Yellin, Michael, Keler, Tibor
Published in Journal for immunotherapy of cancer (01.08.2022)
Published in Journal for immunotherapy of cancer (01.08.2022)
Get full text
Journal Article
Author Correction: BRAFV600E-mutant metastatic NSCLC: disease overview and treatment landscape
Planchard, David, Sanborn, Rachel E, Negrao, Marcelo V, Vaishnavi, Aria, Smit, Egbert F
Published in NPJ precision oncology (15.07.2024)
Published in NPJ precision oncology (15.07.2024)
Get full text
Journal Article
BRAFV600E-mutant metastatic NSCLC: disease overview and treatment landscape
Planchard, David, Sanborn, Rachel E, Negrao, Marcelo V, Vaishnavi, Aria, Smit, Egbert F
Published in NPJ precision oncology (16.04.2024)
Published in NPJ precision oncology (16.04.2024)
Get full text
Journal Article
Development and Preliminary Clinical Activity of PD-1-Guided CTLA-4 Blocking Bispecific DART Molecule
Berezhnoy, Alexey, Sumrow, Bradley J., Stahl, Kurt, Shah, Kalpana, Liu, Daorong, Li, Jonathan, Hao, Su-Shin, De Costa, Anushka, Kaul, Sanjeev, Bendell, Johanna, Cote, Gregory M., Luke, Jason J., Sanborn, Rachel E., Sharma, Manish R., Chen, Francine, Li, Hua, Diedrich, Gundo, Bonvini, Ezio, Moore, Paul A.
Published in Cell reports. Medicine (22.12.2020)
Published in Cell reports. Medicine (22.12.2020)
Get full text
Journal Article
Phase I studies of davoceticept (ALPN-202), a PD-L1-dependent CD28 co-stimulator and dual PD-L1/CTLA-4 inhibitor, as monotherapy and in combination with pembrolizumab in advanced solid tumors (NEON-1 and NEON-2)
Davar, Diwakar, Cavalcante, Ludimila, Lakhani, Nehal, Moser, Justin, Millward, Michael, McKean, Meredith, Voskoboynik, Mark, Sanborn, Rachel E, Grewal, Jaspreet S, Narayan, Ajita, Patnaik, Amita, Gainor, Justin F, Sznol, Mario, Enstrom, Amanda, Blanchfield, Lori, LeBlanc, Heidi, Thomas, Heather, Chisamore, Michael J, Peng, Stanford L, Naumovski, Allison
Published in Journal for immunotherapy of cancer (03.08.2024)
Published in Journal for immunotherapy of cancer (03.08.2024)
Get full text
Journal Article
CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study
Sanborn, Rachel E, Hamid, Omid, de Vries, Elisabeth GE, Ott, Patrick A, Garcia-Corbacho, Javier, Boni, Valentina, Bendell, Johanna, Autio, Karen A, Cho, Daniel C, Plummer, Ruth, Stroh, Mark, Lu, Lawrence, Thistlethwaite, Fiona
Published in Journal for immunotherapy of cancer (01.07.2021)
Published in Journal for immunotherapy of cancer (01.07.2021)
Get full text
Journal Article
A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients With Refractory Thoracic Tumors
Beckermann, Kathryn E., Bestvina, Christine M., El Osta, Badi, Sanborn, Rachel E., Borghaei, Hossein, Lammers, Philip Edward, Selvaggi, Giovanni, Whisenant, Jennifer G., Heimann-Nichols, Ellen, Berry, Lynne, Hsu, Chih-Yuan, Shyr, Yu, Horn, Leora, Wakelee, Heather
Published in JTO clinical and research reports (01.02.2024)
Published in JTO clinical and research reports (01.02.2024)
Get full text
Journal Article
Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer
Massard, Christophe, Gordon, Michael S, Sharma, Sunil, Rafii, Saeed, Wainberg, Zev A, Luke, Jason, Curiel, Tyler J, Colon-Otero, Gerardo, Hamid, Omid, Sanborn, Rachel E, O'Donnell, Peter H, Drakaki, Alexandra, Tan, Winston, Kurland, John F, Rebelatto, Marlon C, Jin, Xiaoping, Blake-Haskins, John A, Gupta, Ashok, Segal, Neil H
Published in Journal of clinical oncology (10.09.2016)
Published in Journal of clinical oncology (10.09.2016)
Get full text
Journal Article
Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor Malignancies
Johnson, Melissa, El-Khoueiry, Anthony, Hafez, Navid, Lakhani, Nehal, Mamdani, Hirva, Rodon, Jordi, Sanborn, Rachel E, Garcia-Corbacho, Javier, Boni, Valentina, Stroh, Mark, Hannah, Alison L, Wang, Song, Castro, Henry, Spira, Alexander
Published in Clinical cancer research (15.08.2021)
Published in Clinical cancer research (15.08.2021)
Get full text
Journal Article
A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer
Sanborn, Rachel E, Ross, Helen J, Aung, Sandra, Acheson, Anupama, Moudgil, Tarsem, Puri, Sachin, Hilton, Traci, Fisher, Brenda, Coffey, Todd, Paustian, Christopher, Neuberger, Michael, Walker, Edwin, Hu, Hong-Ming, Urba, Walter J, Fox, Bernard A
Published in Journal for immunotherapy of cancer (19.12.2017)
Published in Journal for immunotherapy of cancer (19.12.2017)
Get full text
Journal Article
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions
Zhou, Caicun, Tang, Ke-Jing, Cho, Byoung Chul, Liu, Baogang, Paz-Ares, Luis, Cheng, Susanna, Kitazono, Satoru, Thiagarajan, Muthukkumaran, Goldman, Jonathan W, Sabari, Joshua K, Sanborn, Rachel E, Mansfield, Aaron S, Hung, Jen-Yu, Boyer, Michael, Popat, Sanjay, Mourão Dias, Josiane, Felip, Enriqueta, Majem, Margarita, Gumus, Mahmut, Kim, Sang-We, Ono, Akira, Xie, John, Bhattacharya, Archan, Agrawal, Trishala, Shreeve, S Martin, Knoblauch, Roland E, Park, Keunchil, Girard, Nicolas
Published in The New England journal of medicine (30.11.2023)
Published in The New England journal of medicine (30.11.2023)
Get full text
Journal Article
Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205
Dhodapkar, Madhav V, Sznol, Mario, Zhao, Biwei, Wang, Ding, Carvajal, Richard D, Keohan, Mary L, Chuang, Ellen, Sanborn, Rachel E, Lutzky, Jose, Powderly, John, Kluger, Harriet, Tejwani, Sheela, Green, Jennifer, Ramakrishna, Venky, Crocker, Andrea, Vitale, Laura, Yellin, Michael, Davis, Thomas, Keler, Tibor
Published in Science translational medicine (16.04.2014)
Published in Science translational medicine (16.04.2014)
Get more information
Journal Article
Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK+ Lung Cancer
Horn, Leora, Whisenant, Jennifer G., Wakelee, Heather, Reckamp, Karen L., Qiao, Huan, Leal, Ticiana A., Du, Liping, Hernandez, Jennifer, Huang, Vincent, Blumenschein, George R., Waqar, Saiama N., Patel, Sandip P., Nieva, Jorge, Oxnard, Geoffrey R., Sanborn, Rachel E., Shaffer, Tristan, Garg, Kavita, Holzhausen, Allison, Harrow, Kimberly, Liang, Chris, Lim, Lee P., Li, Mark, Lovly, Christine M.
Published in Journal of thoracic oncology (01.11.2019)
Published in Journal of thoracic oncology (01.11.2019)
Get full text
Journal Article
Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVITY-020 Trial
Ascierto, Paolo Antonio, Lipson, Evan J, Dummer, Reinhard, Larkin, James, Long, Georgina V, Sanborn, Rachel E, Chiarion-Sileni, Vanna, Dréno, Brigitte, Dalle, Stéphane, Schadendorf, Dirk, Callahan, Margaret K, Nyakas, Marta, Atkinson, Victoria, Gomez-Roca, Carlos Alberto, Yamazaki, Naoya, Tawbi, Hussein A, Sarkis, Naomey, Warad, Deepti, Dolfi, Sonia, Mitra, Priyam, Suryawanshi, Satyendra, Grob, Jean-Jacques
Published in Journal of clinical oncology (20.05.2023)
Published in Journal of clinical oncology (20.05.2023)
Get full text
Journal Article
Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial
Cho, Byoung Chul, Kim, Dong-Wan, Spira, Alexander I, Gomez, Jorge E, Haura, Eric B, Kim, Sang-We, Sanborn, Rachel E, Cho, Eun Kyung, Lee, Ki Hyeong, Minchom, Anna, Lee, Jong-Seok, Han, Ji-Youn, Nagasaka, Misako, Sabari, Joshua K, Ou, Sai-Hong Ignatius, Lorenzini, Patricia, Bauml, Joshua M, Curtin, Joshua C, Roshak, Amy, Gao, Grace, Xie, John, Thayu, Meena, Knoblauch, Roland E, Park, Keunchil
Published in Nature medicine (01.10.2023)
Published in Nature medicine (01.10.2023)
Get full text
Journal Article